These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15934305)

  • 41. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneous nuclear ribonuclear protein C is increased in the celecoxib-induced growth inhibition of human oral squamous cell carcinoma.
    Lee EJ; Kim SH; Kwark YE; Kim J
    Exp Mol Med; 2006 Jun; 38(3):203-9. PubMed ID: 16819278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Cancer Res; 2006 Dec; 66(23):11115-9. PubMed ID: 17145853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
    Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9.
    Ding H; Han C; Zhu J; Chen CS; D'Ambrosio SM
    Int J Cancer; 2005 Feb; 113(5):803-10. PubMed ID: 15499625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy.
    Kang KB; Zhu C; Yong SK; Gao Q; Wong MC
    Mol Cancer; 2009 Aug; 8():66. PubMed ID: 19706164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
    Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
    Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N; Yamazaki R; Kawai S
    Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of apoptosis by celecoxib in cell culture: an uncertain role for cyclooxygenase-2.
    Schönthal AH
    Cancer Res; 2007 Jun; 67(11):5575-6; author reply 5576. PubMed ID: 17545641
    [No Abstract]   [Full Text] [Related]  

  • 54. A novel celecoxib derivative potently induces apoptosis of human synovial fibroblasts.
    Kusunoki N; Ito T; Sakurai N; Suguro T; Handa H; Kawai S
    J Pharmacol Exp Ther; 2005 Aug; 314(2):796-803. PubMed ID: 15870389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of celecoxib pharmacodynamics in pancreatic cancer.
    Jimeno A; Amador ML; Kulesza P; Wang X; Rubio-Viqueira B; Zhang X; Chan A; Wheelhouse J; Kuramochi H; Tanaka K; Danenberg K; Messersmith WA; Almuete V; Hruban RH; Maitra A; Yeo CJ; Hidalgo M
    Mol Cancer Ther; 2006 Dec; 5(12):3240-7. PubMed ID: 17172427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different cell cycle modulation by celecoxib at different concentrations.
    Kim YM; Pyo H
    Cancer Biother Radiopharm; 2013 Mar; 28(2):138-45. PubMed ID: 23268707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrations.
    Sun SY; Schroeder CP; Yue P; Lotan D; Hong WK; Lotan R
    Cancer Biol Ther; 2005 Apr; 4(4):407-13. PubMed ID: 15846100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of a selective cyclooxygenase-2 inhibitor on cancer cells in vitro.
    Fife RS; Stott B; Carr RE
    Cancer Biol Ther; 2004 Feb; 3(2):228-32. PubMed ID: 14726667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.